© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
October 20, 2021
Taking all 3 doses also helped patients experience higher A1C levels than patients who took titrated insulin glargine, clinical trial results show.
October 15, 2021
Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.
October 11, 2021
Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor.
October 07, 2021
Medication adherence, diet, and exercise are each critical components in caring for patients with a chronic illness, but each is difficult to be managed by physicians alone.
October 01, 2021
The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.
September 30, 2021
Semaglutide (Rybelsus) is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
September 29, 2021
This month's case studies include questions about continuous glucose monitoring, diabetes neuropathic pain, diabetes and colds, and smoking cessation.
T2D is associated with a higher mortality risk linked to the coronavirus than individuals with T1D.
Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.
September 21, 2021
Dasiglucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.